Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/05/2840967/0/en/Tango-Therapeutics-to-Highlight-Preclinical-Data-on-Precision-Oncology-Pipeline-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com/news-release/2024/01/31/2820940/0/en/Tango-Therapeutics-to-Present-at-the-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com//news-release/2024/01/05/2804873/0/en/Tango-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.prnewswire.com/news-releases/medivirs-licensee-tango-therapeutics-has-dosed-the-first-patient-with-tng348-a-novel-usp1-inhibitor-in-a-phase-12-clinical-study-302026095.html
https://www.globenewswire.com//news-release/2024/01/03/2803172/0/en/Tango-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-2-Trial-of-TNG348-in-Patients-with-BRCA1-2-Mutant-and-Other-HRD-Cancers.html
https://www.globenewswire.com//news-release/2023/11/13/2778873/0/en/Tango-Therapeutics-to-Highlight-Preclinical-Data-on-PRMT5-Inhibitors-at-the-Society-for-Neuro-Oncology-SNO-28th-Annual-Meeting.html
https://www.globenewswire.com//news-release/2023/11/08/2776059/0/en/Tango-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Highlights.html